Cipla Company Profile

What is the competitive landscape for CIPLA, and when can generic versions of CIPLA drugs launch?

CIPLA has ninety-two approved drugs.

There are six US patents protecting CIPLA drugs. There are thirty-three tentative approvals on CIPLA drugs.

There are thirty patent family members on CIPLA drugs in twenty-one countries and four hundred and thirty-nine supplementary protection certificates in seventeen countries.

Summary for Cipla

International Patents:	30
US Patents:	6
Tradenames:	81
Ingredients:	81
NDAs:	92
Patent Litigation for Cipla:	See patent lawsuits for Cipla
PTAB Cases with Cipla as petitioner:	See PTAB cases with Cipla as petitioner

Drugs and US Patents for Cipla

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cipla	CELECOXIB	celecoxib	CAPSULE;ORAL	207446-001	Sep 23, 2015	AB	RX	No	No
Cipla	PREGABALIN	pregabalin	CAPSULE;ORAL	212280-008	Jan 10, 2020	AB	RX	No	No
Cipla Ltd	TOPIRAMATE	topiramate	TABLET;ORAL	076343-002	Mar 27, 2009	AB	RX	No	No
Cipla	VALACYCLOVIR HYDROCHLORIDE	valacyclovir hydrochloride	TABLET;ORAL	077135-002	May 24, 2010	AB	RX	No	No
Cipla	ESOMEPRAZOLE MAGNESIUM	esomeprazole magnesium	FOR SUSPENSION, DELAYED RELEASE;ORAL	211751-002	Mar 23, 2020	AB	RX	No	No
Cipla	DECITABINE	decitabine	INJECTABLE;INTRAVENOUS	208601-001	Nov 16, 2017		DISCN	No	No

International Patents for Cipla Drugs

Country	Patent Number	Estimated Expiration
Spain	2613936
World Intellectual Property Organization (WIPO)	2009067692
Japan	5624766
Croatia	P20170154
Taiwan	200927146
World Intellectual Property Organization (WIPO)	2008045410

Supplementary Protection Certificates for Cipla Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1301519	11/2016	Austria		PRODUCT NAME: TENOFOVIRALAFENAMID ODER EIN SALZ ODER SOLVAT DAVON, INSBESONDERE TENOFOVIRALAFENAMIDFUMARAT; REGISTRATION NO/DATE: EU/1/15/1061/001-002 (MITTEILUNG) 20151123
2487166	PA2016038,C2487166	Lithuania		PRODUCT NAME: KOBICISTATAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA IR TENOFOVIRO ALAFENAMIDAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA, YPAC TENOFOVIRO ALAFENAMIDO FUMARATAS; REGISTRATION NO/DATE: EU/1/15/1061 20151119
1632232	300852	Netherlands		PRODUCT NAME: COMBINATIE VAN: - RILPIVIRINEHYDROCHLORIDE OF EEN THERAPEUTISCH EQUIVALENTE VORM DAARVAN ZOALS BESCHERMD DOOR HET BASISOCTROOI; - EMTRICITABINE; EN - TENOFOVIRALAFENAMIDE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, IN HET BIJZONDER TENOFOVIRALAFENAMIDEFUMARAAT; REGISTRATION NO/DATE: EU/1/16/1112 20160623
2487162	1790003-6	Sweden		PRODUCT NAME: COBICISTAT OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND DARUNAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR DARUNAVIR ETHANOLATE FIRST REG.NO: EU/1/14/967, 2014-11-21
1301519	CR 2016 00012	Denmark		PRODUCT NAME: TENOFOVIRALAFENAMID ELLER ET SALT ELLER SOLVAT DERAF, I SAERDELESHED TENOFOVIRALAFENAMIDFUMARAT; REG. NO/DATE: EU/1/15/1061/001-002 20151123
2487163	17C1000	France		PRODUCT NAME: COBICISTAT OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE ET ATAZANAVIR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,EN PARTICULIER LE SULFATE D'ATAZANAVIR; REGISTRATION NO/DATE: EU/1/15/1025 20150715

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Cipla
• Cipla Ltd
• Cipla Usa